Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease
暂无分享,去创建一个
J. Guerin | Y. Agid | B. Bloch | V. Bernard | S. Hunot | E. Leguern | B. Faucheux | E. Hirsch | P. Gautris | C. Brana | F. Boissiere | Y. Agid | B. Faucheux | C. Brana
[1] E. Hirsch,et al. Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in parkinson's disease and rat with 6‐OHDA lesion , 1996, The Journal of comparative neurology.
[2] Y. Agid,et al. Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes , 1996, Neurology.
[3] C. Weickert,et al. GDNF mRNA expression in normal postnatal development, aging, and in weaver mutant mice , 1995, Neurobiology of Aging.
[4] E. Hirsch,et al. Striatal expression of substance P and methionin-enkephalin genes in patients with Parkinson's disease , 1995, Neuroscience Letters.
[5] B. Bloch,et al. Ontogeny of the striatal neurons expressing neuropeptide genes in the human fetus and neonate , 1995, The Journal of comparative neurology.
[6] C. Feuerstein,et al. GDNF: existence of a second transcript in the brain. , 1995, Brain research. Molecular brain research.
[7] E. Mufson,et al. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] Y. Agid,et al. Effects of Nigrostriatal Denervation and L‐Dopa Therapy on the GABAergic Neurons of the Striatum in MPTP‐treated Monkeys and Parkinson's Disease: An In Situ Hybridization Study of GAD67 mRNA , 1995, The European journal of neuroscience.
[9] A. Granholm,et al. Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons , 1995, The Journal of comparative neurology.
[10] Y. Ben-Ari,et al. Cell death, gliosis, and synaptic remodeling in the hippocampus of epileptic rats. , 1995, Journal of neurobiology.
[11] K. Unsicker,et al. TGF‐beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. , 1995, The EMBO journal.
[12] C. Spenger,et al. Comparison of the Effects of the Neurotrophins on the Morphological Structure of Dopaminergic Neurons in Cultures of Rat Substantia Nigra , 1995, The European journal of neuroscience.
[13] L. Bergman,et al. cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle , 1995, Experimental Neurology.
[14] L. Olson,et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo , 1995, Nature.
[15] R. Vandlen,et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain , 1995, Nature.
[16] K. Unsicker,et al. GDNF is expressed in two forms in many tissues outside the CNS. , 1994, Neuroreport.
[17] H. Phillips,et al. TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons , 1994, Neuron.
[18] L. Olson,et al. Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. , 1994, Brain research. Molecular brain research.
[19] S. Wiegand,et al. Efficacy of Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 on Neurochemical and Behavioral Deficits Associated with Partial Nigrostriatal Dopamine Lesions , 1994, Journal of neurochemistry.
[20] J. Trojanowski,et al. Expression of GDNF mRNA in Rat and Human Nervous Tissue , 1994, Experimental Neurology.
[21] E. Jones,et al. Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease , 1994, Neuroscience.
[22] L. Olson,et al. Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger rna in response to kainate-induced excitation , 1994, Neuroscience.
[23] Rhonda,et al. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[24] I. Black,et al. Regional and Cell-Specific Expression of GDNF in Rat Brain , 1993, Experimental Neurology.
[25] L. Olson,et al. Glial Cell Line-Derived Neurotrophic Factor Is Expressed in the Developing but Not Adult Striatum and Stimulates Developing Dopamine Neurons in Vivo , 1993, Experimental Neurology.
[26] J. Fawcett,et al. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons—i. Effectsin vitro , 1993, Neuroscience.
[27] J. Fawcett,et al. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons—II. Effects on nigral transplantsin vivo , 1993, Neuroscience.
[28] F. Hefti,et al. Trophic actions of transforming growth factor α on mesencephalic dopaminergic neurons developing in culture , 1993, Neuroscience.
[29] S. Varon,et al. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Lile,et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.
[31] K. Unsicker,et al. FGF‐2‐mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: Specificity and impact of culture conditions, non‐dopaminergic neurons, and astroglial cells , 1993, Journal of neuroscience research.
[32] F. Hefti,et al. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth FACTOR-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture , 1993, Neuroscience.
[33] E. Hirsch,et al. Glutathione peroxidase, glial cells and Parkinson's disease , 1993, Neuroscience.
[34] Richard S. J. Frackowiak,et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.
[35] Steven A. Johnson,et al. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease , 1991, Neuron.
[36] N. Neff,et al. Epidermal Growth Factor Enhances Striatal Dopaminergic Parameters in the 1‐Methyl‐4‐Phenyl‐l, 2, 3, 6‐Tetrahydropyridine‐Treated Mouse , 1991, Journal of neurochemistry.
[37] K. Unsicker,et al. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] J. Schwaber,et al. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[39] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[40] E. Hirsch,et al. Is dopaminergic cell death accompanied by concomitant nerve plasticity? , 1996, Advances in neurology.
[41] K. Unsicker. Growth factors in Parkinson's disease. , 1994, Progress in growth factor research.
[42] Y Agid,et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease? , 1993, Advances in neurology.